B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

CACNA2D2

MOLECULAR TARGET

calcium voltage-gated channel auxiliary subunit alpha2delta 2

UniProt: Q9NY47NCBI Gene: 92541 compounds

CACNA2D2 (calcium voltage-gated channel auxiliary subunit alpha2delta 2) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting CACNA2D2

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Pregabalin0.691

About CACNA2D2 as a Drug Target

CACNA2D2 (calcium voltage-gated channel auxiliary subunit alpha2delta 2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented CACNA2D2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

CACNA2D2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.